Raj G. Vaghjiani

Surgical Oncology

1005 Harborside Dr
Galveston, TX 77555

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Axillary Management in Clinically Node-Positive (cN1) Estrogen Receptor-Positive Breast Cancer.

Axillary Management in Clinically Node-Positive (cN1) Estrogen Receptor-Positive Breast Cancer.

Journal: Cancers

Published: July 16, 2026

GLP-1 Receptor Agonists versus Bariatric Surgery in Breast Cancer: A Comparative Study of Oncologic Outcomes.

GLP-1 Receptor Agonists versus Bariatric Surgery in Breast Cancer: A Comparative Study of Oncologic Outcomes.

Journal: Annals of surgery

Published: April 13, 2026

Melanoma and Merkel Cell Carcinoma Clinical Trial Status.

Melanoma and Merkel Cell Carcinoma Clinical Trial Status.

Journal: The Surgical clinics of North America

Published: May 24, 2025

Rising Breast Cancer Incidence and Poor Outcomes in Young Women: A Retrospective Study.

Rising Breast Cancer Incidence and Poor Outcomes in Young Women: A Retrospective Study.

Journal: The breast journal

Published: March 01, 2025

Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma.

Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma.

Journal: World journal of oncology

Published: December 09, 2024

Preoperative 18F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma.

Preoperative 18F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma.

Journal: Computational and structural biotechnology journal

Published: August 09, 2023

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: June 04, 2023

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response.

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response.

Journal: Cancers

Published: June 11, 2022

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma.

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 24, 2021

Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.

Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 29, 2019

Decreasing use of epidural analgesia with increasing minimally invasive lobectomy: Impact on postoperative morbidity.

Decreasing use of epidural analgesia with increasing minimally invasive lobectomy: Impact on postoperative morbidity.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 26, 2019

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance.

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance.

Journal: Oncotarget

Published: August 07, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026